Myeloid malignancies with moderate or severe hepatic impairment or normal hepatic function research hub

A Study to Evaluate CC-486 in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Cancer Participants

This study is looking at a medicine called CC-486 in people with cancer who also have liver problems. We want to see how the medicine works differently in people with liver issues compared to those with healthy livers. This will help doctors understand how to give this medicine safely.